Birdwatch Note
2024-08-01 13:20:22 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Imane Khalife não é transsexual. Trata-se de uma mulher que apresenta hiperandrogenia, uma condição natural que resulta em aumento de hormônios masculinos. https://www.sportskeeda.com/mma/news-fact-check-did-imane-khelif-fail-gender-eligibility-test-a-look-algerian-boxer-s-path-paris-olympics
Written by EADAF4AE1C2364D1FB9C30B0EA29B0B4D5F22DE14B6585A7CB8DD075C4BE7890
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1818980732649275496
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819000218706157608
- noteId - 1819000218706157608
- participantId -
- noteAuthorParticipantId - EADAF4AE1C2364D1FB9C30B0EA29B0B4D5F22DE14B6585A7CB8DD075C4BE7890
- createdAtMillis - 1722518422186
- tweetId - 1818980732649275496
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Imane Khalife não é transsexual. Trata-se de uma mulher que apresenta hiperandrogenia, uma condição natural que resulta em aumento de hormônios masculinos. https://www.sportskeeda.com/mma/news-fact-check-did-imane-khelif-fail-gender-eligibility-test-a-look-algerian-boxer-s-path-paris-olympics
Note Ratings
| rated at | rated by | |
| 2024-08-01 22:14:19 -0500 | Rating Details | |
| 2024-08-01 18:35:20 -0500 | Rating Details | |
| 2024-08-01 16:14:32 -0500 | Rating Details | |
| 2024-08-01 14:04:18 -0500 | Rating Details | |
| 2024-08-01 13:15:01 -0500 | Rating Details | |
| 2024-08-01 12:21:49 -0500 | Rating Details | |
| 2024-08-01 11:24:14 -0500 | Rating Details | |
| 2024-08-01 11:17:53 -0500 | Rating Details | |
| 2024-08-01 10:57:37 -0500 | Rating Details | |
| 2024-08-01 10:45:08 -0500 | Rating Details | |
| 2024-08-01 10:40:33 -0500 | Rating Details | |
| 2024-08-01 10:20:08 -0500 | Rating Details | |
| 2024-08-01 10:06:11 -0500 | Rating Details | |
| 2024-08-01 10:02:42 -0500 | Rating Details | |
| 2024-08-01 09:52:19 -0500 | Rating Details | |
| 2024-08-01 09:39:27 -0500 | Rating Details | |
| 2024-08-01 09:31:56 -0500 | Rating Details | |
| 2024-08-01 09:27:50 -0500 | Rating Details | |
| 2024-08-01 09:24:47 -0500 | Rating Details | |
| 2024-08-01 09:24:11 -0500 | Rating Details | |
| 2024-08-01 09:23:31 -0500 | Rating Details | |
| 2024-08-01 09:14:50 -0500 | Rating Details | |
| 2024-08-01 09:14:38 -0500 | Rating Details | |
| 2024-08-01 09:12:03 -0500 | Rating Details | |
| 2024-08-01 09:08:31 -0500 | Rating Details | |
| 2024-08-01 09:01:32 -0500 | Rating Details | |
| 2024-08-01 08:55:40 -0500 | Rating Details | |
| 2024-08-01 08:55:07 -0500 | Rating Details | |
| 2024-08-01 08:44:07 -0500 | Rating Details | |
| 2024-08-01 08:39:42 -0500 | Rating Details | |
| 2024-08-01 08:33:17 -0500 | Rating Details | |
| 2024-08-01 08:28:47 -0500 | Rating Details | |
| 2024-08-01 08:26:45 -0500 | Rating Details | |
| 2024-08-01 08:26:02 -0500 | Rating Details | |
| 2024-08-02 06:45:13 -0500 | Rating Details | |
| 2024-08-01 20:56:23 -0500 | Rating Details | |
| 2024-08-01 20:25:30 -0500 | Rating Details |